NEW YORK, Sept 23 (Reuters) - The head of the U.S. Food and Drug Administration on Wednesday told a U.S. Senate hearing that the agency will vet the safety and effectiveness of COVID-19 vaccines, downplaying the role of the Trump administration in its authorization process.
Career scientists working at the FDA will decide on a vaccine, U.S. FDA Commissioner Dr. Stephen Hahn said.
“FDA will not authorize, or approve a vaccine that we would not feel comfortable giving to our families,” Hahn said. (Reporting by Michael Erman Editing by Chizu Nomiyama)
Our Standards: The Thomson Reuters Trust Principles.